Literature DB >> 13049963

[The nosological place of granuloma gangraescens].

G VOGEL.   

Abstract

Entities:  

Keywords:  GRANULOMA

Mesh:

Year:  1952        PMID: 13049963

Source DB:  PubMed          Journal:  Z Krebsforsch        ISSN: 0301-1585


× No keyword cloud information.
  7 in total

1.  The involvement of the central nervous system in lipoid granulomatosis (Hand-Schüler-Christian disease).

Authors: 
Journal:  Dtsch Med Wochenschr       Date:  1947-09-05       Impact factor: 0.628

2.  Primitive malignant tumors of the nose and throat area (contribution to the question of the meristoma).

Authors:  M LUDIN
Journal:  Pract Otorhinolaryngol (Basel)       Date:  1947

3.  [Not Available].

Authors:  H FRANKE; W SPRENGER
Journal:  Dtsch Arch Klin Med       Date:  1948

4.  Primary plasma-cell tumors of the upper air passages and oral cavity.

Authors:  A P STOUT; F R KENNEY
Journal:  Cancer       Date:  1949-03       Impact factor: 6.860

5.  [Plasma cell tumour (Plasmocytoma) of the maxilla].

Authors:  P BERDAL
Journal:  Nord Med       Date:  1949-02-25

6.  [Relations of hemoblastoses to the reticuloendothelial system].

Authors:  O FRESEN
Journal:  Acta Haematol       Date:  1952-03       Impact factor: 2.195

7.  Plasma cell tumors of the upper respiratory tract; a clinico-pathologic study with emphasis on criteria for histologic diagnosis.

Authors:  A J RAWSON; P W EYLER; R C HORN
Journal:  Am J Pathol       Date:  1950-05       Impact factor: 4.307

  7 in total
  3 in total

1.  [Pathological & anatomical contribution to the pathogenesis & nosological status of malignant granulomas of the nose].

Authors:  H LAPP
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1958

2.  [Not Available].

Authors:  H HUNGER
Journal:  Arch Ohren Nasen Kehlkopfheilkd       Date:  1956

3.  Reticulo-endothelial sarcoma arising in the nose and palate (granuloma gangrenescens).

Authors:  E W WALTON
Journal:  J Clin Pathol       Date:  1960-07       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.